Main public logs
Appearance
Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 09:01, 31 July 2024 EProba talk contribs created page Tan, Y, Li, P (Created page with "{{Author}}")
- 09:01, 31 July 2024 EProba talk contribs created page Publication: Bromelain has significant clinical benefits after extraction of the third molar during chemotherapy in patients with hematologic tumor (Created page with "{{Publication |Title=Tan (2018): Bromelain has significant clinical benefits after extraction of the third molar during chemotherapy in patients with hematologic tumor |Topic=Enzymes (bromelain papain) |Author=Tan, Y; Li, P |Year=2018 |Journal=Oncology letters |DOI=https://doi.org/10.3892/ol.2017.7673 |Authors Abstract=The purpose of this study was to investigate the application of bromelain in the treatment of pain, swelling, and limited mouth opening in patients with h...")
- 13:30, 30 July 2024 Lbordihn talk contribs created page Purified Dry Extract of Paullinia cupana (Guarana ́) (PC-18) for Chemotherapy-Related Fatigue in Patients with Solid Tumors: An Early Discontinuation Study (Created blank page)
- 12:35, 30 July 2024 EProba talk contribs created page Martin et al. (2002): Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial (Created page with "{{Reference |Reference=? }} {{Study Note}} =Brief summary= This study included 56 patients with cancer in the pelvic region. These were different types of cancer, but all patients had their tumours completely removed and underwent radiotherapy. Some of the patients (28 people) also received enzyme therapy in tablet form (10mg papain, 40mg trypsin, 40mg chymotrypsin) and some (28 patients) only received a placebo. The question of this study is whether the additional enzym...")
- 11:15, 30 July 2024 EProba talk contribs created page Martin, T, Uhder, K, Kurek, R, Roeddiger, S, Schneider, L, Vogt, HG, Heyd, R, Zamboglou, N (Created page with "{{Author}}")
- 11:14, 30 July 2024 EProba talk contribs created page Publication: Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial (Created page with "{{Publication |Title=Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial |Topic=Enzymes (bromelain papain) |Author=Martin, T; Uhder, K; Kurek, R; Roeddiger, S; Schneider, L; Vogt, HG; Heyd, R; Zamboglou, N. |Year=2002 |Journal=Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology |DOI=https://doi.org/10.1016/S0167-8140(02)00192-5 G...")
- 10:20, 29 July 2024 Lbordihn talk contribs created page De Giglio (2013): Purified Dry Extract of Paullinia cupana (Guarana ́) (PC-18) for Chemotherapy-Related Fatigue in Patients with Solid Tumors: An Early Discontinuation Study (Created page with "{{Reference |Reference=Purified Dry Extract of Paullinia cupana (Guarana ́) (PC-18) for Chemotherapy-Related Fatigue in Patients with Solid Tumors: An Early Discontinuation Study }} {{Study Note}} =Brief summary= In this study, researchers investigated the effect of guarana on patients with different types of cancer who suffered from fatigue after chemotherapy. After a three-week induction phase in which all patients received guarana, those who responded to the treatmen...")
- 10:16, 29 July 2024 Lbordihn talk contribs created page Publication: Purified Dry Extract of Paullinia cupana (Guarana ́) (PC-18) for Chemotherapy-Related Fatigue in Patients with Solid Tumors: An Early Discontinuation Study (Created page with "{{Publication |Title=Publication: Purified Dry Extract of Paullinia cupana (Guarana ́) (PC-18) for Chemotherapy-Related Fatigue in Patients with Solid Tumors: An Early Discontinuation Study |Topic=Guarana |Author=Braz del Giglio, A; de Iracema Gomes Cubero, D; Goberstein Lerner, T; Tuma Guariento, R; Guise Soares de Azevedo, R; Paiva, H; Goldman, C; Carelli, B; Melo Cruz, F; Schindler, F; Pianowski, L; Luongo de Matos, L; del Giglio, A |Year=2013 |Journal=Journal of Die...")
- 10:54, 28 July 2024 Lbordihn talk contribs created page Da Costa et al. (2009): Effectiveness of Guarana (Paullinia cupana) for Postradiation Fatigue and Depression Results of a Pilot Double-Blind Randomized Study (Created page with "{{Reference |Reference=Publication: Effectiveness of Guarana (Paullinia cupana) for Postradiation Fatigue and Depression Results of a Pilot Double-Blind Randomized Study }} {{Study Note}} =Brief summary= Similar to the study described above, researchers in this study also investigated the effect of guarana on chemotherapy-induced fatigue in patients with breast cancer. For 14 days, half of the women were asked to take guarana once a day, while the other half took a place...")
- 10:48, 28 July 2024 Lbordihn talk contribs created page Publication: Effectiveness of Guarana (Paullinia cupana) for Postradiation Fatigue and Depression Results of a Pilot Double-Blind Randomized Study (Created page with "{{Publication |Title=Publication: Effectiveness of Guarana (Paullinia cupana) for Postradiation Fatigue and Depression Results of a Pilot Double-Blind Randomized Study |Topic=Guarana |Author=da Costa Miranda, V; Trufelli, DC; Santos, J; Paschoin Campos, M; Nobuo, M; da Costa Miranda, M; Schlinder, F; Riechelmann, R; del Giglio, A |Year=2009 |Journal=The journal of alternative and complementary medicine |DOI=https://doi.org/10.1089=acm.2008.0324 |Authors Abstract=Context...")
- 13:37, 26 July 2024 JDoerfler talk contribs created page Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia (Created page with "{{Reference |Reference=Publication: Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia }} {{Study Note}} =Brief summary= This study was conducted with 332 patients and investigated the influence of carnitine, MPA/MA, EPA, thalidomide and a combination medication (carnitine + MPA/MA + EPA + thalidomide) on weight (fat mass and muscle mass) over 16 weeks in patients with acute weight loss due to cancer. The results...")
- 13:34, 26 July 2024 JDoerfler talk contribs created page Publication: Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia (Created page with "{{Publication |Title=Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia |Topic=Carnitine |Author=Mantovani, G; Macciò, A; Madeddu, C; Serpe, R; Massa, E; Dessì, M; Panzone, F; Contu, P |Year=2010 |Journal=The oncologist |DOI=https://doi.org/10.1634/theoncologist.2009-0153 |Authors Abstract=Purpose. A phase III, randomized study was carried out to establish the most effective and safest treatment to improve the...")
- 11:33, 26 July 2024 DDeel talk contribs created page Strasser et al. (2006): Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled (…) (Created page with "{{Reference |Reference=Publication: Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled (…) }} {{Study Note}} =Brief summary= The study included 243 patients with various types of advanced cancer. Randomly divided into 3 arms, one received a cannabis extract (THC and cannabidiol) for 6 weeks, one onl...")
- 11:25, 26 July 2024 DDeel talk contribs created page Publication: Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled (…) (Created page with "{{Publication |Title=Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group |Topic=Cannabinoids |Author=Strasser, F; Luftner, D; Possinger, K; Ernst, G; Ruhstaller, T; Meissner, W; Ko, YD; Schnelle, M; Reif, M; Cerny, T |Year=2006 |Journal=Journal o...")
- 10:26, 26 July 2024 DDeel talk contribs created page Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue (Created page with "{{Reference |Reference=Publication: A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Cou...")
- 10:25, 26 July 2024 DDeel talk contribs created page Publication: A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue (Created page with "{{Publication |Title=A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue |Topic=Aloe vera |Author=Heggie, S; Bryant, GP; Tripcony, L; Keller, J; Rose, P; Glendenning, M; Heath, J |Year=2002 |Journal=Cancer Nursing |DOI=https://doi.org/10.1097/00002820-200212000-00007 |Authors Abstract=The aim of the study was to see if topical aloe vera gel would be beneficial in reducing the identified skin side-effects of radiation therapy, including...")
- 12:44, 25 July 2024 Cotto talk contribs created page MediaWiki:Common.js (Created page with "Any JavaScript here will be loaded for all users on every page load.: $(document).ready(function() { $('table.wikitable td').each(function() { var cellContent = $(this).text().trim(); if (cellContent === 'low risk') { $(this).addClass('low-risk'); } else if (cellContent === 'some concerns') { $(this).addClass('some-concerns'); } else if (cellContent === 'high risk') { $(this).addClass('high-ris...")
- 11:55, 25 July 2024 Cotto talk contribs created page MediaWiki:Common.css (Created page with "CSS placed here will be applied to all skins: input[value="low risk"] { accent-color: green; margin: 0px; } input[value="some concerns"] { accent-color: orange; margin: 0px; } input[value="high risk"] { accent-color: red; margin: 0px; } #pfForm > div.mw-parser-output > div:nth-child(32) > div.multipleTemplateList > div.multipleTemplateInstance.multipleTemplate > table > tbody > tr > td.instanceMain > table > tbody > tr:nth-child(n+1):nth-...")
- 15:00, 23 July 2024 EProba talk contribs created page Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers (Created page with "{{Reference |Reference=Publication: Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers }} {{Study Note}} =Brief summary= This study included 100 patients with head and neck cancer who received radiotherapy. One arm of 53 people also received enzyme therapy in tablet form (10mg papain, 40mg trypsin, 40mg chymotrypsin), which was taken during radiotherapy. A further arm of 47 people, on the other hand,...")
- 14:51, 23 July 2024 EProba talk contribs created page Gujral, MS; Patnaik, PM; Kaul, R; Parikh, HK; Conradt, C; Tamhankar, CP; Daftary, GV (Created page with "{{Author}}")
- 14:50, 23 July 2024 EProba talk contribs created page Publication: Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers (Created page with "{{Publication |Title=Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers |Topic=Enzymes (bromelain papain) |Author=Gujral, MS; Patnaik, PM; Kaul, R; Parikh, HK; Conradt, C; Tamhankar, CP; Daftary, GV |Year=2001 |Journal=Cancer Chemotherapy and Pharmacology |DOI=https://doi.org/10.1007/s002800170005 |Authors Abstract=Purpose: Based on in vitro and on clinical evidence of protection against acute side e...")
- 12:28, 23 July 2024 JDoerfler talk contribs created page Kraft et al. (2012): L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial (Created page with "{{Reference |Reference=Publication: L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial }} {{Study Note}} =Brief summary= This study included 72 patients with advanced pancreatic cancer who were randomly and fairly evenly divided into two groups. One group received the carnitine and the other group the placebo. The authors investigated the influence of carnitine on the weight caused by the disease, as well as the influence...")
- 12:09, 23 July 2024 JDoerfler talk contribs created page Publication: L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial (Created page with "{{Publication |Title=L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial |Topic=Carnitine |Author=Kraft, M; Kraft, K; Gärtner, S; Mayerle, J; Simon, P; Weber, E; Schütte, K; Stieler, J; Koula-Jenik, H; Holzhauer, P; Gröber, U; Engel, G; Müller, C; Feng, YS; Aghdassi, A; Nitsche, C; Malfertheiner, P; Patrzyk, M; Kohlmann, T; Lerch, MM |Year=2012 |Journal=Deutsche Zeitschrift für Onkologie |DOI=http://www.nutritionj.com/...")
- 09:30, 23 July 2024 JDoerfler talk contribs created page Koyama et al. (2017): Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients (Created page with "{{Reference |Reference=Publication: Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients }} {{Study Note}} =Brief summary= The study investigated the influence of carnitine on the inflammatory and insulin response in patients following surgery for gastric or colorectal cancer. Eight patients were randomly assigned to the control group, who received the usual...")
- 09:27, 23 July 2024 JDoerfler talk contribs created page Publication: Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients (Created page with "{{Publication |Title=Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients |Topic=Carnitine |Author=Koyama Y; Moro K; Nakano M; Miura K; Nagahashi M; Kosugi S-i; Tsuchida J; Ikarashi M; Nakajima M; Ichikawa H; Hanyu T; Shimada Y; Sakata J; Kameyama H; Kobayashi T; Wakai T |Year=2017 |Journal=Journal of clinical medicine research |DOI=https://doi.org/10.14740/j...")
- 15:37, 22 July 2024 EProba talk contribs created page Dörr et al. (2007): Efficacy of Wobe-Mugos E for Reduction of Oral Mucositis after Radiotherapy (Created page with "{{Reference |Reference=Publication: Efficacy of Wobe-Mugos E for Reduction of Oral Mucositis after Radiotherapy }} {{Study Note}} =Brief summary= This study included 69 patients with cancer of the mouth and throat who received radiotherapy. One arm of 36 people also received enzyme therapy in tablet form (10mg papain, 40mg trypsin, 40mg chymotrypsin), which was taken during radiotherapy. In contrast, another arm of 33 people received a placebo. The question of this stud...")
- 14:52, 22 July 2024 EProba talk contribs created page Dörr, W; Herrmann, T (Created page with "{{Author}}")
- 14:46, 22 July 2024 EProba talk contribs created page Publication: Efficacy of Wobe-Mugos E for Reduction of Oral Mucositis after Radiotherapy (Created page with "{{Publication |Title=Efficacy of Wobe-Mugos® E for Reduction of Oral Mucositis after Radiotherapy |Topic=Enzymes (bromelain papain) |Author=Dörr, W; Herrmann, T |Year=2007 |Journal=Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft |DOI=https://doi.org/10.1007/s00066-007-1634-0 |Authors Abstract=Purpose: To investigate the efficacy and safety of Wobe-Mugos® E (proteolytic enzymes) for amelioration of early side effects of radiotherapy for head-...")
- 12:36, 22 July 2024 Lbordihn talk contribs created page Campos et al. (2011): Guarana (Paullinia cupana) Improves Fatigue in Breast Cancer Patients Undergoing Systemic Chemotherapy (Created page with "{{Reference |Reference=Guarana (Paullinia cupana) Improves Fatigue in Breast Cancer Patients Undergoing Systemic Chemotherapy }} {{Study Note |Study Note=Fatigue is a common side effect of chemotherapy. In this study, researchers investigated the effect of guarana on chemotherapy-induced fatigue in patients with breast cancer. Researchers studied 75 women with increasing fatigue or who developed fatigue after chemotherapy. For 21 days, half of the women were asked to tak...")
- 12:31, 22 July 2024 Lbordihn talk contribs created page Publication: Guarana (Paullinia cupana) Improves Fatigue in Breast Cancer Patients Undergoing Systemic Chemotherapy (Created page with "{{Publication |Title=Publication: Guarana (Paullinia cupana) Improves Fatigue in Breast Cancer Patients Undergoing Systemic Chemotherapy |Topic=Guarana |Author=Campos, M; Riechelmann, R; Martins, L; Hassan, B; Casa, F; Del Giglio, A |Year=2011 |Journal=The journal of alternative and complementary medicine |DOI=https://doi.org/10.1089/acm.2010.0571 |Authors Abstract=Background: In patients with breast cancer (BC) undergoing systemic chemotherapy, cancer-related fatigue (C...")
- 12:25, 22 July 2024 JDoerfler talk contribs created page Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy (Created page with "{{Reference |Reference=Publication: Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy }} {{Study Note}} =Brief summary= This large-scale study, initially involving 409 breast cancer patients, focused primarily on the effect of carnitine on peripheral neuropathy (an increased toxicity in the brain that negatively affects all functions of the body) caused...")
- 12:12, 22 July 2024 JDoerfler talk contribs created page Publication: Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy (Created page with "{{Publication |Title=Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy |Topic=Carnitine |Author=Hershman, DL; Unger, JM; Crew, KD; Minasian, LM; Awad, D; Moinpour, CM; Hansen, L; Lew, DL; Greenlee, H; Fehrenbacher, L; Wade, JL; Wong, SF; Hortobagyi, GN; Meyskens, FL; Albain, KS |Year=2013 |Journal=Journal of clinical oncology: official journal of the Am...")
- 08:51, 22 July 2024 JDoerfler talk contribs created page Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial (Created page with "{{Reference |Reference=Publication: L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial }} {{Study Note}} =Brief summary= 376 patients with different types of cancer took part in this study to investigate carnitine on tiredness/fatigue caused by cancer or the associated chemotherapy and medication. They were randomly assigned to 2 groups, one...")
- 08:46, 22 July 2024 JDoerfler talk contribs created page Publication: L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial (Created page with "{{Publication |Title=L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial |Topic=Carnitine |Author=Cruciani, RA; Zhang, JJ; Manola, J; Cella, D; Ansari, B; Fisch, MJ |Year=2012 |Journal=Journal of clinical oncology: official journal of the American Society of Clinical Oncology |DOI=https://doi.org/10.1200/JCO.2011.40.2180 |Authors Abstract=Pur...")
- 06:07, 19 July 2024 Lbordihn talk contribs created page Togni et al. (2015): Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial (Created page with "{{Reference |Reference=Publication:Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial }} {{Study Note |Study Note=? }} =Brief summary= Radiotherapy is a common cancer treatment. Many patients experience skin reactions due to radiotherapy. In this study, researchers examined the efficacy of a cream containing Boswellia serrata. Women scheduled...")
- 09:30, 18 July 2024 DDeel talk contribs moved page Publication: An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity to Publication: An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of (...) without leaving a redirect
- 09:29, 18 July 2024 DDeel talk contribs moved page Minchom et al. (2014): An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of ... to Minchom et al. (2014): An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of (...) without leaving a redirect
- 09:28, 17 July 2024 VMathies talk contribs created page Liu et al. (2010): Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial (Created page with "{{Reference |Reference=Publication: Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial }} {{Study Note |Study Note=? }} =Brief summary= In this study, four different arms of thyroid cancer patients were examined, each beginning at different times to suck dissolved vitamin C in addition to radioiodine therapy to stimulate saliva flow (1, 5, 13, or 25 hours after radioiodine therapy...")
- 09:21, 17 July 2024 VMathies talk contribs created page Publication: Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial (Created page with "{{Publication |Title=Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial |Topic=Vitamin C |Author=Liu, B; Kuang, A; Huang, R; Zhao, Z; Zeng, Y; Wang, J; Tian, R |Year=2010 |Journal=Journal of nuclear medicine |DOI=http://dx.doi.org/10.2967/jnumed.109.071449 |Authors Abstract=In this study, vitamin C was administered at various times as a sour stimulant to thyroid cancer patients, a...")
- 14:18, 16 July 2024 JDoerfler talk contribs created page Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study (Created page with "{{Reference |Reference=Publication: L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study }} {{Study Note}} =Brief summary= The study investigated the impact of carnitine on fatigue/exhaustion caused by cancer and the associated chemotherapy and medication. A total of 33 patients with various cancers and a carnitine deficiency caused by the treatment were randomly assigned to two groups. One group...")
- 14:04, 16 July 2024 DDeel talk contribs created page Chung et al. (2026): Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer (Created page with "{{Reference |Reference=Publication: Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analys...")
- 14:04, 16 July 2024 DDeel talk contribs created page Publication: Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer (Created page with "{{Publication |Title=Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer |Topic=Vitamin C, Vitamin E |Author=Chung, MK; Kim, DH; Ahn, YC; Choi, JY; Kim, EH; Son, YI |Year=2016 |Journal=Otolaryngology – Head and Neck Surgery |DOI=https://doi.org/10.1177/0194599816642418 |Authors Abstract=Objective. The present study was conducted to determine the preventive efficacy of vitamin C/E complex suppleme...")
- 13:38, 16 July 2024 JDoerfler talk contribs created page Publication: L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study (Created page with "{{Publication |Title=L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study |Topic=Carnitine |Author=Cruciani, RA; Dvorkin, ED; Homel, P; Culliney, B; Malamud, S; Lapin, J; Portenoy, RK; Esteban-Cruciani, N |Year=2009 |Journal=Journal of pain and symptom management |DOI=https://doi.org/10.1016/j.jpainsymman.2008.03.021 |Authors Abstract=Carnitine deficiency is prevalent in populations with chronic i...")
- 12:28, 16 July 2024 DDeel talk contribs created page Minchom et al. (2014): An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of ... (Created page with "{{Reference |Reference=Publication: An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity }} {{Study Note}} =Brief summary= Minchom and colleagues (2014) investigated the effect of a vitamin combination of vitamin B12 and folic acid on grade 3 and 4 neutropenia, a side effect that can occur as...")
- 12:18, 16 July 2024 DDeel talk contribs created page Publication: An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity (Created page with "{{Publication |Title=An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity |Topic=Folic acid, Vitamin B12 |Author=Minchom, AR; Saksornchai, K; Bhosle, J; Gunapala, R; Puglisi, M; Lu, SK; Nimako, K; Coward, J; Yu, KC; Bordi, P; Popat, S; O’Brien, MER |Year=2014 |Journal=JBMJ Open Respiratory...")
- 11:57, 16 July 2024 JDoerfler talk contribs created page Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy (Created page with "{{Reference |Reference=Publication: Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy }} {{Study Note}} =Brief summary= This study investigated the effect of carnitine as an adjuvant to the usual medication (sildenafil) in erectile dysfunction following prostatectomy. Ninety-six patients participated in the study, of which 29 were in the control...")
- 10:00, 16 July 2024 JDoerfler talk contribs created page Publication: Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy (Created page with "{{Publication |Title=Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy |Topic=Carnitine |Author=Cavallini, G; Modenini, F; Vitali, G; Koverech, A |Year=2005 |Journal=Urology |DOI=https://doi.org/10.1016/j.urology.2005.05.014 |Authors Abstract=Objectives To determine whether propionyl-l-carnitine (PLC) plus acetyl-l-carnitine (ALC) improves the e...")
- 09:47, 16 July 2024 DDeel talk contribs created page Rostock et al. (2013): Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Four-Arm Randomized Trial on the Effectiveness of Electroacupuncture (Created page with "{{Reference |Reference=Publication: Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Four-Arm Randomized Trial on the Effectiveness of Electroacupuncture }} {{Study Note}} =Brief summary= In the study by Rostock and colleagues, 59 patients who were currently undergoing a rehabilitation program after chemotherapy were examined. They were randomly divided into four arms and examined over three weeks. The arms received either electroacupuncture, hydroelectri...")
- 09:22, 16 July 2024 DDeel talk contribs created page Publication: Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Four-Arm Randomized Trial on the Effectiveness of Electroacupuncture (Created page with "{{Publication |Title=Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Four-Arm Randomized Trial on the Effectiveness of Electroacupuncture |Topic=Vitamin B1, Vitamin B6, Electroacupuncture |Author=Rostock, M; Jaroslawski, K; Guethlin, C; Ludtke, R; Schröder, S; Bartsch, HH |Year=2013 |Journal=Evidence-based Complementary and Alternative Medicine |DOI=http://dx.doi.org/10.1155/2013/349653 |Authors Abstract=Purpose. Chemotherapy-induced peripheral neuropat...")
- 09:12, 16 July 2024 JDoerfler talk contribs created page Ryan et al. (2013): Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients (Created page with "{{Reference |Reference=Publication: Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients }} {{Study Note}} =Brief summary= =Study Design= In this study, breast cancer patients were examined during radiotherapy, with one half taking curcumin alongside radiotherapy and the other half taking a placebo. In the curcumin group, the severity of radiodermatitis (a common skin disease associated with ra...")